AU2007247497A1 - Biomarkers for endometrial proliferation - Google Patents

Biomarkers for endometrial proliferation Download PDF

Info

Publication number
AU2007247497A1
AU2007247497A1 AU2007247497A AU2007247497A AU2007247497A1 AU 2007247497 A1 AU2007247497 A1 AU 2007247497A1 AU 2007247497 A AU2007247497 A AU 2007247497A AU 2007247497 A AU2007247497 A AU 2007247497A AU 2007247497 A1 AU2007247497 A1 AU 2007247497A1
Authority
AU
Australia
Prior art keywords
gene
alpha
collagen
type
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007247497A
Other languages
English (en)
Inventor
Maria Bobadilla
Salah-Dine Chibout
Andre Cordier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2007247497A1 publication Critical patent/AU2007247497A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
AU2007247497A 2006-04-28 2007-04-26 Biomarkers for endometrial proliferation Abandoned AU2007247497A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0608483.4A GB0608483D0 (en) 2006-04-28 2006-04-28 Biomarkers for endometrial proliferation
GB0608483.4 2006-04-28
PCT/EP2007/003694 WO2007128429A1 (en) 2006-04-28 2007-04-26 Biomarkers for endometrial proliferation

Publications (1)

Publication Number Publication Date
AU2007247497A1 true AU2007247497A1 (en) 2007-11-15

Family

ID=36590031

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007247497A Abandoned AU2007247497A1 (en) 2006-04-28 2007-04-26 Biomarkers for endometrial proliferation

Country Status (10)

Country Link
EP (1) EP2016417A1 (ja)
JP (1) JP2009535023A (ja)
KR (1) KR20090009212A (ja)
CN (1) CN101427139A (ja)
AU (1) AU2007247497A1 (ja)
BR (1) BRPI0710912A2 (ja)
CA (1) CA2648165A1 (ja)
GB (1) GB0608483D0 (ja)
MX (1) MX2008013789A (ja)
WO (1) WO2007128429A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078728A1 (en) * 2008-01-14 2009-07-15 Université de Liège Novel isoform of versican and use in diagnosis and therapy
JP2024518180A (ja) * 2021-05-17 2024-04-25 エフ． ホフマン－ラ ロシュ アーゲー 腺筋症の非侵襲的診断のための血液バイオマーカーとしてのｓＦＲＰ４

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1159601A (en) * 1999-11-03 2001-05-14 Metris Therapeutics Limited Agents implicated in endometriosis
US20050214836A1 (en) * 2002-08-30 2005-09-29 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis
WO2004056858A2 (en) * 2002-12-23 2004-07-08 Ingenium Pharmaceuticals Ag Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders

Also Published As

Publication number Publication date
WO2007128429A1 (en) 2007-11-15
JP2009535023A (ja) 2009-10-01
EP2016417A1 (en) 2009-01-21
CA2648165A1 (en) 2007-11-15
BRPI0710912A2 (pt) 2012-02-22
CN101427139A (zh) 2009-05-06
MX2008013789A (es) 2008-11-14
GB0608483D0 (en) 2006-06-07
KR20090009212A (ko) 2009-01-22

Similar Documents

Publication Publication Date Title
JP6446381B2 (ja) ｃ−ＭＡＦを用いた前立腺がん転移の診断、予後診断および処置のための方法
US20060134688A1 (en) Genes overexpressed in prostate disorders as diagnostic and therapeutic targets
JP2009535642A (ja) 非アルコール性脂肪性肝炎（ｎａｓｈ）を診断及び予測する方法
WO2004076682A2 (en) Targets for controlling cellular growth and for diagnostic methods
Tschugguel et al. Induction of inducible nitric oxide synthase expression in human secretory endometrium
AU3839400A (en) Proliferation inhibitor for androgen-independent tumor
JP2005110602A (ja) アトピー性皮膚炎の疾患マーカー及びその利用
KR101820572B1 (ko) 만성골수성백혈병에 관한 정보 제공 방법
EP1537243A1 (en) Method of diagnosing ovarian endometriosis
US20220065859A1 (en) Application of ERH Gene in the Preparation of Bladder Cancer Diagnosis and Treatment Products
CN109952511B (zh) 用于确定先兆子痫的风险的测定方法
JP2010185878A (ja) 栄養膜細胞の細胞死、分化、浸潤、および／または細胞融合および代謝回転に関連する状態の診断用組成物および治療方法
AU2007247497A1 (en) Biomarkers for endometrial proliferation
WO2002022858A9 (en) Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
KR100948808B1 (ko) 간암 마커로서의 ｌｃｎ2 유전자, 단백질 및 간암 진단키트
US20060188885A1 (en) High throughput functional genomic screening methods for osteoarthritis
JP2002517209A (ja) 子宮内膜症の診断および処置におけるプロサイモシンの使用
JP4120778B2 (ja) 骨代謝異常疾患マーカー及びその利用
US20030096781A1 (en) IL-8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma
Dang et al. Androgen receptor (CAG) n polymorphisms and breast cancer risk in a Han Chinese population
KR100861464B1 (ko) 발암/전이유전자 ｔｉｐ41과 이에 의해 코드되는 단백질 및이를 이용한 발암 및 전이 진단 키트
CN111197088A (zh) Adamtsl3作为腹主动脉瘤诊治标志物的应用
US20120195916A1 (en) Method of treating cancer by inhibiting trim59 expression or activity
CN114134232B (zh) Hds在预测胃癌患者的预后、指导术后辅助化疗和预测免疫治疗疗效中的应用
US20060128644A1 (en) Use of mob-5 in pain

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted